Researchers develop world's most sensitive test to detect infectious disease, superbugs

July 6, 2015, McMaster University
Yingfu Li is a professor in the Departments of Biochemistry and Biomedical Sciences, Chemistry and Chemical Biology. Credit: McMaster University

Infectious diseases such as hepatitis C and some of the world's deadliest superbugs—C. difficile and MRSA among them—could soon be detected much earlier by a unique diagnostic test, designed to easily and quickly identify dangerous pathogens.

Researchers at McMaster University have developed a new way to detect the smallest traces of metabolites, proteins or fragments of DNA. In essence, the new method can pick up any compound that might signal the presence of infectious disease, be it respiratory or gastrointestinal.

"The method we have developed allows us to detect targets at levels that are unprecedented," says John Brennan, director of McMaster's Biointerfaces Institute, where the work was done. This new method is described online in the journal Angewandte Chemie International Edition.

"The test has the best sensitivity ever reported for a detection system of this kind - it is as much as 10,000 times more sensitive than other detection systems," he says.

Using sophisticated techniques, researchers developed a molecular device made of DNA that can be switched 'on' by a specific molecule of their choice—such as a certain type of disease indicator or DNA molecule representing a genome of a virus—an action that leads to a massive, amplified signal which can be easily spotted.

Another important advantage of the new test, say researchers, is that the method does not require complicated equipment so tests can be run at room temperature under ordinary conditions.

"This will be the foundation for us to create future ", explains Yingfu Li, a professor in the Departments of Biochemistry and Biomedical Sciences, Chemistry and Chemical Biology.

"This invention will allow us to detect anything we might be interested in, bacterial contamination or perhaps a that is a cancer marker. Our can sensitively detect all of them, and it can do so in a relatively short period of time."

Researchers are currently working to move the test onto a paper surface to create a portable point-of-care test, which would completely eliminate the need for lab instruments, allowing users—family physicians, for example—to run the test.

The Biointerfaces Institute has developed a series of paper-based screening technologies which enable users to generate clear, simple answers that appear on test paper indicating the presence of infection or contamination in people, food or the environment.

Explore further: Office inkjet printer could produce simple tool to identify infectious diseases

Related Stories

A non-invasive tool for diagnosing cancer

May 20, 2015

Researchers in Singapore have developed an ultrasensitive method to detect micro-RNAs: tiny molecules that can indicate the presence of tumours. They are applying the technology toward a non-invasive screening test for gastric ...

A simple diagnostic test to detect tuberculosis in humans

May 29, 2015

Tuberculosis (TB) represents a growing worldwide healthcare burden. Second only to HIV in terms of its global impact, TB infected 8.5 million people and caused 1.4 million deaths in 2011. If these statistics are to improve, ...

Hunting for deadly bacteria

April 12, 2011

( -- You can't see them, or smell them or taste them. They can be in our water and in our food, multiplying so rapidly that conventional testing methods for detecting pathogens such as E.coli, salmonella and listeria ...

Recommended for you

Chemical waves guide to catalysts of the future

February 20, 2018

Spectacular electron microscope images at TU Wien lead to important findings: Chemical reactions can produce spiral-like multi-frequency waves and thus provide local information about catalysts.

Engineers test drug transfer using placenta-on-a-chip

February 16, 2018

Researchers at the University of Pennsylvania's School of Engineering and Applied Science have demonstrated the feasibility of their "organ-on-a-chip" platform in studying how drugs are transported across the human placental ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.